Back to Journals » Clinical Interventions in Aging » Volume 12

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Total article views   HTML views PDF downloads Totals
33,737 Dovepress* 22,381+ 3,433 25,814
PubMed Central* 11,356 2,201 13,557
Totals 33,737 5,634 39,371
*Since 18 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
32 0 0 0 14 18

View citations on PubMed Central and Google Scholar